This document defines dysmenorrhea and amenorrhea, discusses their causes, symptoms, diagnosis, and management. Dysmenorrhea is painful menstruation that can be primary, caused by prostaglandins, or secondary, due to underlying conditions. Symptoms include cramping pain relieved by NSAIDs, birth control, or heat. Amenorrhea is the absence of menstruation and can be primary or secondary. Causes include hypothalamic, pituitary, or ovarian dysfunction. Evaluation involves examining for secondary sex characteristics and testing hormone levels. Management aims to address the underlying cause, enable fertility if desired, and prevent complications through hormone replacement if needed.
This document summarizes hormonal methods of contraception. It describes family planning and the criteria for an ideal contraceptive. Hormonal contraceptives are classified as oral pills, depot formulations, injections, subdermal implants, and vaginal rings. Combined oral contraceptive pills contain estrogen and progesterone while progesterone-only pills contain only progesterone. Depot formulations provide long-lasting, reversible contraception through injections or implants. The various hormonal methods, their mechanisms of action, effectiveness, advantages, and potential side effects are discussed.
Hormone replacement therapy (HRT) provides relief from post-menopausal symptoms and long-term health benefits by replacing hormones lost during menopause. It is commonly used to treat hot flashes, night sweats, and risks of osteoporosis and heart disease. Estrogen is the primary hormone replaced through various oral pills, patches, implants, or creams. Progestin is often added for women with a uterus to prevent potential health risks. HRT regimens aim to mimic the body's natural hormone levels and cycles. While generally effective and beneficial, HRT also carries some health risks if used long-term such as potential increased risks of blood clots, breast cancer, or endometrial
Oral contraceptive pills contain estrogen and progesterone hormones that prevent pregnancy through three main mechanisms: blocking ovulation, thickening cervical mucus to prevent sperm entry, and changing the uterine lining. They are a popular, effective, and relatively safe contraceptive method with potential side effects like headaches, mood changes, and weight gain. Proper use and avoiding certain drug interactions are important for preventing contraceptive failure and unplanned pregnancy.
This document summarizes different types of oral contraceptives including hormonal and non-hormonal options. It describes combined oral contraceptives which contain both estrogen and progesterone. Progestin-only and emergency contraceptives are also discussed. The mechanisms of action, advantages, disadvantages and side effects of each type are outlined. Guidelines for use, missed pill protocols, and medical eligibility criteria are provided.
This document defines premenstrual syndrome as the occurrence of cyclical somatic, psychological, and emotional symptoms that occur in the luteal phase of the menstrual cycle and resolve when menstruation begins. It estimates that almost all women experience some symptoms, while 5% have severe symptoms. The causes are unknown but may involve hormonal fluctuations or low serotonin levels. Common symptoms include mood changes, cognitive issues, pain, and disruptions to daily life. Diagnosis involves tracking symptoms over multiple cycles. Management options range from lifestyle changes to various supplements, medications, and in rare cases, surgery. Assessing treatment effectiveness is difficult due to high placebo response rates.
This document discusses contraception and various contraceptive methods. It defines contraception as any method used to prevent pregnancy and notes its importance in allowing people to choose whether and when to have children. The document then covers female contraception methods including hormonal methods like combined oral contraception (COC), progestogen-only methods, emergency contraception, and natural family planning methods. It discusses the effectiveness, advantages, and disadvantages of each method.
Menopause is the time in a woman's life when her period stops. It usually occurs naturally, most often after age 45. Menopause happens because the woman's ovaries stop producing the hormones estrogen and progesterone. A woman has reached menopause when she has not had a period for one year.
This document summarizes hormonal methods of contraception. It describes family planning and the criteria for an ideal contraceptive. Hormonal contraceptives are classified as oral pills, depot formulations, injections, subdermal implants, and vaginal rings. Combined oral contraceptive pills contain estrogen and progesterone while progesterone-only pills contain only progesterone. Depot formulations provide long-lasting, reversible contraception through injections or implants. The various hormonal methods, their mechanisms of action, effectiveness, advantages, and potential side effects are discussed.
Hormone replacement therapy (HRT) provides relief from post-menopausal symptoms and long-term health benefits by replacing hormones lost during menopause. It is commonly used to treat hot flashes, night sweats, and risks of osteoporosis and heart disease. Estrogen is the primary hormone replaced through various oral pills, patches, implants, or creams. Progestin is often added for women with a uterus to prevent potential health risks. HRT regimens aim to mimic the body's natural hormone levels and cycles. While generally effective and beneficial, HRT also carries some health risks if used long-term such as potential increased risks of blood clots, breast cancer, or endometrial
Oral contraceptive pills contain estrogen and progesterone hormones that prevent pregnancy through three main mechanisms: blocking ovulation, thickening cervical mucus to prevent sperm entry, and changing the uterine lining. They are a popular, effective, and relatively safe contraceptive method with potential side effects like headaches, mood changes, and weight gain. Proper use and avoiding certain drug interactions are important for preventing contraceptive failure and unplanned pregnancy.
This document summarizes different types of oral contraceptives including hormonal and non-hormonal options. It describes combined oral contraceptives which contain both estrogen and progesterone. Progestin-only and emergency contraceptives are also discussed. The mechanisms of action, advantages, disadvantages and side effects of each type are outlined. Guidelines for use, missed pill protocols, and medical eligibility criteria are provided.
This document defines premenstrual syndrome as the occurrence of cyclical somatic, psychological, and emotional symptoms that occur in the luteal phase of the menstrual cycle and resolve when menstruation begins. It estimates that almost all women experience some symptoms, while 5% have severe symptoms. The causes are unknown but may involve hormonal fluctuations or low serotonin levels. Common symptoms include mood changes, cognitive issues, pain, and disruptions to daily life. Diagnosis involves tracking symptoms over multiple cycles. Management options range from lifestyle changes to various supplements, medications, and in rare cases, surgery. Assessing treatment effectiveness is difficult due to high placebo response rates.
This document discusses contraception and various contraceptive methods. It defines contraception as any method used to prevent pregnancy and notes its importance in allowing people to choose whether and when to have children. The document then covers female contraception methods including hormonal methods like combined oral contraception (COC), progestogen-only methods, emergency contraception, and natural family planning methods. It discusses the effectiveness, advantages, and disadvantages of each method.
Menopause is the time in a woman's life when her period stops. It usually occurs naturally, most often after age 45. Menopause happens because the woman's ovaries stop producing the hormones estrogen and progesterone. A woman has reached menopause when she has not had a period for one year.
This document provides information about premature ejaculation (PE), including its causes, diagnosis, and treatment options. PE is characterized by a lack of control over ejaculation and many men experience it occasionally. It is controlled by the central nervous system and can have psychological or biological causes like serotonin levels. Treatments include behavioral therapies like squeeze or stop-start methods, medications like antidepressants, and anesthetic creams applied to the penis. Psychological therapy can also help address relationship issues that may contribute to PE.
This document presents a case of a 44-year-old woman presenting with abnormal uterine bleeding for 23 days. Her workup showed severe anemia. She was diagnosed with AUB and treated with blood transfusions. Abnormal uterine bleeding is defined as bleeding outside normal volume, duration, or frequency. It can be caused by various structural, hematological, endocrine or other issues. Dysfunctional uterine bleeding is defined as abnormal bleeding without an organic cause, and can be ovulatory or anovulatory. Initial management of AUB involves determining the cause and treating any underlying issues medically or surgically.
This document discusses the diagnosis and management of menstrual disorders. It begins by reviewing normal menstrual physiology and providing terminology used to describe different types of menstrual disorders. It then discusses the general approach to taking a history and performing an examination for patients presenting with menstrual complaints. Specific sections cover the evaluation and treatment of dysmenorrhea, menorrhagia, amenorrhea, and anovulatory bleeding. Causes and management approaches are provided for different menstrual disorders.
This document defines and discusses andropause (also known as male menopause), including its definition, symptoms, epidemiology, pathophysiology, effects of testosterone deficiency, monitoring and risks/benefits of testosterone replacement therapy. Some key points are: andropause is characterized by declining testosterone levels and affects quality of life; symptoms include reduced energy, libido and erectile dysfunction; prevalence increases with age, with 20% of men over 60 and 50% of men over 75 having low testosterone; testosterone replacement can improve symptoms in men with very low levels if administered carefully under medical supervision due to risks like prostate issues.
Neural tube defects: Importance of Folic Acid and Vitamin B12 intakeVijaya Sawant,PMP, OCP
Birth defects are a global problem, but their impact is particularly severe in middle and low income countries where more than 94 percent of the births with serious birth defects and 95 percent of the deaths of these children occur. Serious birth defect can be lethal. For those who survive, these disorders can cause lifelong mental, physical, auditory or visual disability. The report shows that at least 3.3 million children under five years of age die from birth defects each years. More than 70% of birth defects can be prevented. Educate the community about the birth defects and the opportunities for effective care and prevention.
Use of progesterone in obstetrics & gynaecology namkha presentsnamkha dorji
This document discusses the use of progesterone in obstetrics and gynecology. It provides a brief history of progesterone, noting its discovery and isolation in the 1920s. It describes progesterone's natural sources and functions, including roles in the menstrual cycle, pregnancy, and development of female secondary sex characteristics. The document also outlines progesterone's mechanisms of action, pharmacological properties, indications for various obstetric and gynecologic conditions, and potential side effects. It reviews data on progesterone's effectiveness in preventing preterm birth and miscarriage.
This document discusses various conditions related to menstruation and the female reproductive system. It provides information on normal menstrual cycles and what constitutes irregular or abnormal bleeding. It describes specific conditions such as amenorrhea, dysmenorrhea, menorrhagia, oligomenorrhea, premature ovarian failure, uterine fibroids, and endometriosis. For each condition, it outlines common signs and symptoms women may experience.
Dr. Ann Steiner, Clinical Professor of OBGYN at Penn Medicine, discusses the changes that happen as a woman's body goes through menopause, as well as treating symptoms that result from these hormonal changes.
The document summarizes the female menstrual cycle, which occurs approximately every 28 days. It describes the ovarian and uterine cycles, including the follicular phase where an egg matures and is released (ovulation), the luteal phase where the corpus luteum forms, and the proliferative and secretory phases in the uterus. Key hormones like FSH, LH, estrogen, and progesterone regulate the cycle through feedback mechanisms between the hypothalamus, pituitary gland, and ovaries. Abnormalities in the cycle can occur if ovulation does not take place.
Menstruation is a visible manifestation of the cyclic, hormonally-driven shedding of the uterine lining. It results from the interplay of hormones through the hypothalamic-pituitary-ovarian axis. The menstrual cycle consists of two concurrent cycles - the ovarian cycle involving follicular development and ovulation, and the uterine cycle involving proliferation and shedding of the endometrium. The ovarian cycle is regulated by hormones including estrogen, progesterone, FSH and LH which act at different phases to recruit follicles, select a dominant follicle, trigger ovulation, and support luteal function if pregnancy does not occur.
Menopause typically occurs between ages 49-52 as the ovaries gradually slow production of eggs and reproductive hormones, causing menstrual periods to stop. It may be induced by surgery or occur prematurely under age 40. Symptoms include hot flashes, mood changes, and increased risk of osteoporosis and heart disease due to hormonal changes. Hormone replacement therapy can help treat symptoms but also carries risks if used long term. Maintaining a healthy lifestyle through diet, exercise, avoiding smoking and limiting alcohol can also help manage menopausal effects.
This document discusses different types of intrauterine contraceptive devices (IUCDs), including non-medicated, copper-containing, and hormone-containing IUCDs. It provides examples of specific IUCD brands. The document also addresses ideal candidates for IUCDs, contraindications, complications, and strategies to reduce risks like pelvic inflammatory disease. Case studies are presented and answered to demonstrate how IUCD eligibility and management would be assessed.
LNG-IUS: heavy menstrual bleeding What is new??? Dr. Jyoti Agarwal / Dr. Sha...Lifecare Centre
The document discusses the use of levonorgestrel-releasing intrauterine systems (LNG-IUS), such as Mirena, for treating heavy menstrual bleeding. It provides an overview of LNG-IUS, including how it works locally in the uterus to reduce bleeding. Studies show LNG-IUS reduces bleeding by over 90% and is more effective than oral treatments. It is recommended as the first-line treatment for heavy bleeding by international guidelines and has fewer side effects than other options like endometrial ablation or hysterectomy. LNG-IUS is found to improve quality of life more than surgical treatments and is more cost-effective in the long run.
This document discusses menstrual disorders and provides information about normal menstrual cycles as well as common disorders. It describes that a normal menstrual cycle is typically between 20-40 days with bleeding lasting 2-7 days and average blood loss of 40cc. Common symptoms include cramps and feelings of unpleasantness due to hormonal withdrawal. Main disorders discussed are premenstrual syndrome (PMS), abnormal menstruation, and dysfunctional uterine bleeding (DUB). PMS occurs in the 4-5 days before a period due to water and electrolyte imbalance from estrogen. Abnormal menstruation encompasses conditions like menorrhagia and metrorrhagia. DUB results in excessive bleeding that is irregular in duration, amount and frequency
Hormone replacement therapy (HRT) can help relieve menopausal symptoms, prevent osteoporosis, and maintain quality of life during menopause. It is recommended for women experiencing premature menopause or those who had surgical menopause. HRT improves hot flashes, urogenital atrophy, and bone mineral density while reducing risks of fractures, colorectal cancer, and possibly heart disease. However, HRT may increase risks of blood clots, breast cancer, gallbladder disease, and dementia. The benefits and risks depend on dosage and treatment duration, so the lowest effective dose is recommended for short periods of time.
This document discusses menstrual disorders including amenorrhea and dysmenorrhea. Amenorrhea is defined as the absence of menstruation and can be primary or secondary. It has functional and structural causes and is treated non-pharmacologically or with drugs depending on the underlying cause. Dysmenorrhea refers to painful cramps during menstruation and can be primary or secondary. Risk factors, signs and symptoms, and treatment with NSAIDs, oral contraceptives, or non-pharmacological methods are described. Primary dysmenorrhea is treated by relieving cramping while secondary dysmenorrhea treatment focuses on the underlying organic cause.
Primolut N (Generic Norethisterone Tablets) can be used in several different circumstances to treat irregular, painful or heavy periods, Dysfuntional uterine bleeding, Polymenorrhoea, Menorrhagia, Metropathia, Haemorrhagia, to treat endometriosis (where tissue from the lining of the womb is present inplaces where it is not normally found), to treat premenstrual syndrome (also known as premenstrual tension, PMS or PMT) and to delay periods.
At high dose Primolut N tablets are used to treat disseminated carcinoma of the breast.
This document provides information on endometriosis including its definition, incidence, pathophysiology, risk factors, symptoms, diagnosis, and treatment options. Some key points:
- Endometriosis is a condition where endometrial tissue grows outside the uterus, most commonly on the ovaries, pelvic peritoneum, and ligaments. Its cause is unknown but theories include retrograde menstruation and immune/genetic factors.
- It has a prevalence of 10% in women between menarche and menopause. Symptoms include pelvic pain, dysmenorrhea, and infertility.
- Diagnosis involves physical exam, ultrasound, and laparoscopy. Treatment options include pain management
This document provides information about female sexual anatomy and the menstrual cycle. It describes the external genitals including the vulva, clitoris, labia, and vaginal opening. It then discusses the internal reproductive organs such as the uterus, fallopian tubes, and ovaries. It explains menstruation and how the ovaries and hormones regulate the menstrual cycle. The document also covers menstrual products and potential issues like toxic shock syndrome and premenstrual syndrome.
The term metrorrhagia is often used for irregular menstruation that occurs between the expected menstrual periods. Oligomenorrhea is the medical term for infrequent, often light menstrual periods (intervals exceeding 35 days). Amenorrhea is the absence of a menstrual period in a woman of reproductive age.
This document outlines the course content for a gynaecology course. It will cover topics such as anatomy and physiology, gynaecological assessment, common disorders including menstrual disorders, abortions, pelvic congestion syndrome and ectopic pregnancy. Specific conditions like dysfunctional uterine bleeding, threatened abortion and septic abortion will also be described in terms of definition, causes, signs/symptoms, management and complications.
This document provides information about premature ejaculation (PE), including its causes, diagnosis, and treatment options. PE is characterized by a lack of control over ejaculation and many men experience it occasionally. It is controlled by the central nervous system and can have psychological or biological causes like serotonin levels. Treatments include behavioral therapies like squeeze or stop-start methods, medications like antidepressants, and anesthetic creams applied to the penis. Psychological therapy can also help address relationship issues that may contribute to PE.
This document presents a case of a 44-year-old woman presenting with abnormal uterine bleeding for 23 days. Her workup showed severe anemia. She was diagnosed with AUB and treated with blood transfusions. Abnormal uterine bleeding is defined as bleeding outside normal volume, duration, or frequency. It can be caused by various structural, hematological, endocrine or other issues. Dysfunctional uterine bleeding is defined as abnormal bleeding without an organic cause, and can be ovulatory or anovulatory. Initial management of AUB involves determining the cause and treating any underlying issues medically or surgically.
This document discusses the diagnosis and management of menstrual disorders. It begins by reviewing normal menstrual physiology and providing terminology used to describe different types of menstrual disorders. It then discusses the general approach to taking a history and performing an examination for patients presenting with menstrual complaints. Specific sections cover the evaluation and treatment of dysmenorrhea, menorrhagia, amenorrhea, and anovulatory bleeding. Causes and management approaches are provided for different menstrual disorders.
This document defines and discusses andropause (also known as male menopause), including its definition, symptoms, epidemiology, pathophysiology, effects of testosterone deficiency, monitoring and risks/benefits of testosterone replacement therapy. Some key points are: andropause is characterized by declining testosterone levels and affects quality of life; symptoms include reduced energy, libido and erectile dysfunction; prevalence increases with age, with 20% of men over 60 and 50% of men over 75 having low testosterone; testosterone replacement can improve symptoms in men with very low levels if administered carefully under medical supervision due to risks like prostate issues.
Neural tube defects: Importance of Folic Acid and Vitamin B12 intakeVijaya Sawant,PMP, OCP
Birth defects are a global problem, but their impact is particularly severe in middle and low income countries where more than 94 percent of the births with serious birth defects and 95 percent of the deaths of these children occur. Serious birth defect can be lethal. For those who survive, these disorders can cause lifelong mental, physical, auditory or visual disability. The report shows that at least 3.3 million children under five years of age die from birth defects each years. More than 70% of birth defects can be prevented. Educate the community about the birth defects and the opportunities for effective care and prevention.
Use of progesterone in obstetrics & gynaecology namkha presentsnamkha dorji
This document discusses the use of progesterone in obstetrics and gynecology. It provides a brief history of progesterone, noting its discovery and isolation in the 1920s. It describes progesterone's natural sources and functions, including roles in the menstrual cycle, pregnancy, and development of female secondary sex characteristics. The document also outlines progesterone's mechanisms of action, pharmacological properties, indications for various obstetric and gynecologic conditions, and potential side effects. It reviews data on progesterone's effectiveness in preventing preterm birth and miscarriage.
This document discusses various conditions related to menstruation and the female reproductive system. It provides information on normal menstrual cycles and what constitutes irregular or abnormal bleeding. It describes specific conditions such as amenorrhea, dysmenorrhea, menorrhagia, oligomenorrhea, premature ovarian failure, uterine fibroids, and endometriosis. For each condition, it outlines common signs and symptoms women may experience.
Dr. Ann Steiner, Clinical Professor of OBGYN at Penn Medicine, discusses the changes that happen as a woman's body goes through menopause, as well as treating symptoms that result from these hormonal changes.
The document summarizes the female menstrual cycle, which occurs approximately every 28 days. It describes the ovarian and uterine cycles, including the follicular phase where an egg matures and is released (ovulation), the luteal phase where the corpus luteum forms, and the proliferative and secretory phases in the uterus. Key hormones like FSH, LH, estrogen, and progesterone regulate the cycle through feedback mechanisms between the hypothalamus, pituitary gland, and ovaries. Abnormalities in the cycle can occur if ovulation does not take place.
Menstruation is a visible manifestation of the cyclic, hormonally-driven shedding of the uterine lining. It results from the interplay of hormones through the hypothalamic-pituitary-ovarian axis. The menstrual cycle consists of two concurrent cycles - the ovarian cycle involving follicular development and ovulation, and the uterine cycle involving proliferation and shedding of the endometrium. The ovarian cycle is regulated by hormones including estrogen, progesterone, FSH and LH which act at different phases to recruit follicles, select a dominant follicle, trigger ovulation, and support luteal function if pregnancy does not occur.
Menopause typically occurs between ages 49-52 as the ovaries gradually slow production of eggs and reproductive hormones, causing menstrual periods to stop. It may be induced by surgery or occur prematurely under age 40. Symptoms include hot flashes, mood changes, and increased risk of osteoporosis and heart disease due to hormonal changes. Hormone replacement therapy can help treat symptoms but also carries risks if used long term. Maintaining a healthy lifestyle through diet, exercise, avoiding smoking and limiting alcohol can also help manage menopausal effects.
This document discusses different types of intrauterine contraceptive devices (IUCDs), including non-medicated, copper-containing, and hormone-containing IUCDs. It provides examples of specific IUCD brands. The document also addresses ideal candidates for IUCDs, contraindications, complications, and strategies to reduce risks like pelvic inflammatory disease. Case studies are presented and answered to demonstrate how IUCD eligibility and management would be assessed.
LNG-IUS: heavy menstrual bleeding What is new??? Dr. Jyoti Agarwal / Dr. Sha...Lifecare Centre
The document discusses the use of levonorgestrel-releasing intrauterine systems (LNG-IUS), such as Mirena, for treating heavy menstrual bleeding. It provides an overview of LNG-IUS, including how it works locally in the uterus to reduce bleeding. Studies show LNG-IUS reduces bleeding by over 90% and is more effective than oral treatments. It is recommended as the first-line treatment for heavy bleeding by international guidelines and has fewer side effects than other options like endometrial ablation or hysterectomy. LNG-IUS is found to improve quality of life more than surgical treatments and is more cost-effective in the long run.
This document discusses menstrual disorders and provides information about normal menstrual cycles as well as common disorders. It describes that a normal menstrual cycle is typically between 20-40 days with bleeding lasting 2-7 days and average blood loss of 40cc. Common symptoms include cramps and feelings of unpleasantness due to hormonal withdrawal. Main disorders discussed are premenstrual syndrome (PMS), abnormal menstruation, and dysfunctional uterine bleeding (DUB). PMS occurs in the 4-5 days before a period due to water and electrolyte imbalance from estrogen. Abnormal menstruation encompasses conditions like menorrhagia and metrorrhagia. DUB results in excessive bleeding that is irregular in duration, amount and frequency
Hormone replacement therapy (HRT) can help relieve menopausal symptoms, prevent osteoporosis, and maintain quality of life during menopause. It is recommended for women experiencing premature menopause or those who had surgical menopause. HRT improves hot flashes, urogenital atrophy, and bone mineral density while reducing risks of fractures, colorectal cancer, and possibly heart disease. However, HRT may increase risks of blood clots, breast cancer, gallbladder disease, and dementia. The benefits and risks depend on dosage and treatment duration, so the lowest effective dose is recommended for short periods of time.
This document discusses menstrual disorders including amenorrhea and dysmenorrhea. Amenorrhea is defined as the absence of menstruation and can be primary or secondary. It has functional and structural causes and is treated non-pharmacologically or with drugs depending on the underlying cause. Dysmenorrhea refers to painful cramps during menstruation and can be primary or secondary. Risk factors, signs and symptoms, and treatment with NSAIDs, oral contraceptives, or non-pharmacological methods are described. Primary dysmenorrhea is treated by relieving cramping while secondary dysmenorrhea treatment focuses on the underlying organic cause.
Primolut N (Generic Norethisterone Tablets) can be used in several different circumstances to treat irregular, painful or heavy periods, Dysfuntional uterine bleeding, Polymenorrhoea, Menorrhagia, Metropathia, Haemorrhagia, to treat endometriosis (where tissue from the lining of the womb is present inplaces where it is not normally found), to treat premenstrual syndrome (also known as premenstrual tension, PMS or PMT) and to delay periods.
At high dose Primolut N tablets are used to treat disseminated carcinoma of the breast.
This document provides information on endometriosis including its definition, incidence, pathophysiology, risk factors, symptoms, diagnosis, and treatment options. Some key points:
- Endometriosis is a condition where endometrial tissue grows outside the uterus, most commonly on the ovaries, pelvic peritoneum, and ligaments. Its cause is unknown but theories include retrograde menstruation and immune/genetic factors.
- It has a prevalence of 10% in women between menarche and menopause. Symptoms include pelvic pain, dysmenorrhea, and infertility.
- Diagnosis involves physical exam, ultrasound, and laparoscopy. Treatment options include pain management
This document provides information about female sexual anatomy and the menstrual cycle. It describes the external genitals including the vulva, clitoris, labia, and vaginal opening. It then discusses the internal reproductive organs such as the uterus, fallopian tubes, and ovaries. It explains menstruation and how the ovaries and hormones regulate the menstrual cycle. The document also covers menstrual products and potential issues like toxic shock syndrome and premenstrual syndrome.
The term metrorrhagia is often used for irregular menstruation that occurs between the expected menstrual periods. Oligomenorrhea is the medical term for infrequent, often light menstrual periods (intervals exceeding 35 days). Amenorrhea is the absence of a menstrual period in a woman of reproductive age.
This document outlines the course content for a gynaecology course. It will cover topics such as anatomy and physiology, gynaecological assessment, common disorders including menstrual disorders, abortions, pelvic congestion syndrome and ectopic pregnancy. Specific conditions like dysfunctional uterine bleeding, threatened abortion and septic abortion will also be described in terms of definition, causes, signs/symptoms, management and complications.
Topic of presentation: Amenorrhea. Content includes: Introduction, Etiology, signs and symptoms, classification, diagnosis and management with treatment. How it can be prevented. Both the types: Primary and secondary are discussed.
This document discusses abnormal uterine bleeding (AUB), which refers to menstrual bleeding that differs in quantity, duration, or schedule from normal. AUB is a common gynecological complaint that can be caused by structural issues like fibroids or polyps, hormonal imbalances, or systemic diseases. The document outlines the evaluation, differential diagnosis, and treatment options for AUB, emphasizing history, physical exam, diagnostic testing, and addressing the underlying cause. Treatment involves medication, procedures, or surgery depending on the identified etiology.
This document discusses abnormal uterine bleeding (AUB), which refers to menstrual bleeding that differs in quantity, duration, or schedule from normal. AUB is a common gynecological complaint that can be caused by structural issues like fibroids or polyps, hormonal imbalances, or systemic diseases. The document outlines the evaluation, diagnosis, and treatment of AUB, including taking a medical history, performing exams and tests, considering potential etiologies, and treating underlying causes. Treatment depends on the identified cause and may involve medication, procedures like polypectomy, or surgery.
This document discusses abnormal uterine bleeding, including its definition, causes, approach to diagnosis, and management. It defines different types of abnormal bleeding and notes that the most common causes in reproductive-aged women are ovulatory dysfunction and anovulation. The initial workup involves a medical history, physical exam, and basic lab tests. Further testing may include ultrasounds, endometrial biopsies, or hysteroscopies. Treatment depends on the underlying cause but often involves hormonal therapy as first-line treatment or surgical options if medical management fails or is contraindicated.
This document discusses various menstrual disorders including amenorrhea, dysmenorrhea, dysfunctional bleeding, premenstrual syndrome, pelvic inflammatory disease, endometriosis, pelvic relaxation disorders, cystitis, urinary incontinence, and perimenopause. It defines each condition, discusses etiology and pathophysiology, assessment findings, diagnosis, and treatment. Nursing considerations are provided for educating women on prevention and management of these common gynecological issues.
Menstrual disorders are common in adolescents. Normal menstrual cycles typically involve the release of an egg each month under control of the hypothalamic-pituitary-ovarian axis. Abnormal uterine bleeding can include heavy or irregular bleeding. Common causes of menstrual problems include polycystic ovarian syndrome, bleeding disorders, and anovulation. Treatment depends on the underlying cause but may include birth control pills, NSAIDs, or surgery.
This document provides an overview of amenorrhea, beginning with definitions and classifications of primary and secondary amenorrhea. It then discusses the pathophysiology of the hypothalamic-pituitary-ovarian axis and menstrual cycle. The main causes of amenorrhea are outlined, including physiological causes as well as disorders of the hypothalamus, pituitary, thyroid, adrenals, ovaries, and uterus. The document describes the clinical evaluation of amenorrheic patients, including taking a thorough medical history and conducting a physical exam and laboratory investigations. Finally, medical and surgical treatment options are presented depending on the underlying cause of the amenorrhea.
Absent or irregular periods??
Menstrual cycle disorders can cause a woman’s periods to be absent or infrequent. Although some women do not mind missing their menstrual period, these changes should always be discussed with a healthcare provider because they can signal underlying medical conditions and potentially have long-term health consequences. A woman who misses more than three menstrual periods (either consecutively or over the course of a year) should see a healthcare provider.
This document discusses various types of menstrual disorders including menorrhagia, amenorrhea, oligomenorrhea, and dysmenorrhea. It defines these conditions and discusses their causes such as fibroids, polyps, endometriosis, thyroid disease, and coagulopathies. The document outlines how to evaluate patients with menstrual disorders including relevant history, lab tests, imaging studies, and procedures. It also reviews medical and surgical treatment options.
Amenorrhea is defined as the absence of menstrual bleeding and can be primary or secondary. Primary amenorrhea refers to the absence of periods by age 14 with no sexual development, or by age 16 with normal development. Secondary amenorrhea involves the stopping of periods in a woman with normal previous cycles. Amenorrhea can be caused by issues with the hypothalamus, pituitary gland, ovaries, or uterus interfering with hormone production and regulation of the menstrual cycle. Common symptoms include a lack of periods, breast milk production without pregnancy, headaches, and vision changes. Tests and exams like blood work, imaging scans, and procedures evaluate hormone levels and identify potential causes. Treatment options consist of hormone therapy, medications, surgery
Menopause is a biological stage in a woman's life that occurs when she stops menstruating and reaches the end of her natural reproductive life. This is not usually abrupt, but a gradual process during which women experience perimenopause before reaching post-menopause”
This document discusses various gynecological infections and abnormalities. It begins by defining and describing dysmenorrhea (painful periods) and its causes. It then discusses premenstrual syndrome (PMS), defining it as a cluster of physical and psychological symptoms before menstruation. Precipitating factors and common symptoms of PMS are provided. Treatment options for both dysmenorrhea and PMS focus on reducing pain and inflammation. These include NSAIDs, oral contraceptives, exercise, and tranquilizers or diuretics to help manage mood changes and bloating respectively.
This document discusses puberty, the menstrual cycle, and abnormal uterine bleeding. It begins by defining puberty and explaining the physiological changes and hormonal control of puberty onset. It then discusses the menstrual cycle in detail, explaining the ovarian, endometrial, and hormonal regulation of the cycle. Finally, it defines abnormal uterine bleeding and discusses various causes and treatments of menstrual disorders.
This document discusses various menstrual disorders including amenorrhea, dysmenorrhea, endometriosis, oligomenorrhea/hypomenorrhea, metrorrhagia, menorrhagia, and dysfunctional uterine bleeding. It defines each disorder, discusses their causes and symptoms, and outlines treatment options which may include counseling, medication, surgery, or lifestyle changes. Management is tailored to the underlying cause and aims to control symptoms, address anatomical issues, and prevent future complications.
This document discusses amenorrhea, including its causes, evaluation, and management. It begins by defining amenorrhea and classifying it as primary or secondary. The causes of amenorrhea are then categorized based on the site of disturbance - the outflow tract, ovary, anterior pituitary, or hypothalamus. For each site, the document lists specific disorders that could cause amenorrhea and discusses the evaluation and management. Hypothalamic and pituitary causes of secondary amenorrhea are emphasized, outlining treatments like lifestyle modifications and hormone therapy.
Menstrual irregularities are the problems with a girl's normal monthly menses. For example, missed periods, have them too frequently, having painful periods, or have excessively heavy flow. Menstrual irregularities can sometimes be a sign of an underlying health problem.
Similar to 2. Dysmenorrhea and Amenorrhea PG.ppt (20)
This document discusses nutrition for critically ill patients. It outlines nutritional risk assessment tools, energy and protein needs, and enteral feeding protocols. For the case, it recommends starting enteral nutrition as soon as hemodynamically stable, with a calorie target of 25-30 kcal/kg ideal body weight per day, or 1250-1500 kcal for a 50kg man. Locally available formulas like Plumpy'Nut and Mumbai formula are options for enteral feeding in the ICU.
This document provides an overview of sedation, analgesia, and delirium management in the intensive care unit (ICU). It discusses pain in critically ill patients, common painful procedures, and tools for pain assessment. It covers pharmacological and non-pharmacological approaches to pain management, including regional analgesia, opioid analgesics like fentanyl and morphine, and non-opioid options. The document also addresses goals of sedation in the ICU, scales for sedation monitoring, benzodiazepines, dexmedetomidine, propofol and their properties and adverse effects. Finally, it briefly discusses delirium and its management.
This document discusses vasoactive agents used to treat shock. It outlines different types of shock including septic, cardiogenic, and hypovolemic shock. It describes the autonomic nervous system and types of adrenergic receptors. Various vasopressors and inotropes are presented including norepinephrine, dopamine, epinephrine, vasopressin, and phenylephrine. Their mechanisms, dosages, and indications for treating shock are provided. Maintaining adequate perfusion and tissue oxygen delivery is critical for treatment.
This document provides an overview of fluid management for a patient admitted to the ICU. It discusses fluid types, their components and uses. It describes how to assess a patient's fluid status and calculate fluid requirements. The document outlines fluid monitoring, electrolyte disorders like hyponatremia and hypernatremia, and their management. It emphasizes the importance of maintaining fluid balance and addressing imbalances to support organ function.
A 29-year old male with no previous medical history was admitted to the ICU after a car crash with multiple trauma requiring laparotomy. He is intubated, sedated and on noradrenaline with low blood pressure and heart rate. A feeding tube was inserted into his jejunum. The discussion points are about when to start nutrition, what the energy target should be, and how to manage hypoglycemia. The document discusses the risks and benefits of early enteral nutrition in the ICU, optimal routes, timing and formulations of feeding as well as monitoring for complications. It also covers indications for parenteral nutrition and management of hypoglycemia.
Electrolytes like sodium, potassium, calcium, and magnesium are important minerals in the body that regulate functions like nerve impulses, muscle contraction, and fluid balance. Sodium is the main cation in extracellular fluid and helps maintain fluid balance and nerve transmission. Potassium is mainly intracellular and regulates muscle contraction and acid-base balance. Common electrolyte imbalances include hyponatremia (low sodium), hypernatremia (high sodium), hypokalemia (low potassium), and hyperkalemia (high potassium). Their causes, clinical effects, and management strategies are discussed.
Critically ill patients are susceptible to short- and long-term complications. Implementing proven best practices through checklists, bundles, and interdisciplinary rounds can help prevent these complications. A bundle is a set of evidence-based interventions that improve patient outcomes more than any single intervention alone, such as the ABCDEF bundle which is shown to reduce ICU length of stay, delirium, and mortality.
This document discusses various clinical syndromes related to COVID-19 including:
- Mild to severe pneumonia characterized by cough and respiratory symptoms. Severe pneumonia can progress to ARDS.
- ARDS is identified by acute hypoxemic respiratory failure, bilateral lung opacities, and onset within one week of a known clinical insult or infection.
- Sepsis is defined as a dysregulated immune response to infection leading to life-threatening organ dysfunction. Septic shock involves circulatory and metabolic abnormalities requiring vasopressors.
This document describes the case of a 35-year-old obese woman presenting with fever, myalgia, fatigue, cough, shortness of breath, and respiratory distress who is suspected of having COVID-19 or another respiratory infection. Upon initial examination, she requires high-flow oxygen and has diffuse crackles on lung exam and bilateral infiltrates on chest x-ray. She deteriorates clinically and requires intubation and mechanical ventilation. Over the following days, her condition gradually improves with treatment but she initially fails attempts at breathing trials due to anxiety and high respiratory rate and volume. After diuresis to correct fluid balance and a subsequent successful breathing trial, she demonstrates readiness for extubation.
This document discusses the principles of documentation in the ICU. It outlines what should be documented, including assessments, clinical problems, communications, medications, plans of care, and special considerations. Documentation is important for communication among healthcare professionals, and has several uses like ensuring quality care, credentialing, addressing legal issues, and supporting research. The principles of documentation include producing high quality, accurate records in a timely manner according to policies and protecting patient privacy and confidentiality. Entries should be authenticated, dated, and use standard terminology. Documentation provides evidence for appropriate decision making and care.
7-Dead body management in a covid patient.pptxMesfinShifara
Dead body management of COVID-19 patients should follow standard infection prevention and control practices. The major steps are: 1) preparing the body in the patient room while preventing exposure to fluids, 2) transferring the body wrapped in cloth to the morgue, 3) cleaning and disinfecting surfaces, 4) burial following physical distancing with PPE-wearing burial teams, and 5) cleaning equipment and practicing hand hygiene before returning home. Proper cleaning, disinfection, PPE use, and minimizing contact with fluids are essential throughout the process.
This document discusses various oxygen delivery devices and airway management techniques. It describes nasal prongs, simple face masks, and non-rebreather masks, and how they can provide different fractions of inspired oxygen (FiO2). It also outlines techniques for using face masks, as well as other simple airway maneuvers like positioning and oral/nasal airways. Finally, it discusses criteria for considering intubation in a patient, including objective criteria based on blood gases and ventilation, as well as subjective criteria like decreasing mental status or signs of respiratory failure.
This document discusses mechanical ventilation, including its definition, indications, goals, settings, modes, parameters, monitoring, and criteria for extubation. Mechanical ventilation uses machines to assist or replace spontaneous breathing. Common indications include inadequate ventilation or oxygenation. Goals are to achieve adequate oxygenation and carbon dioxide removal while solving ventilatory problems. Ventilator settings include variables like trigger, control, and cycling that determine breath initiation and delivery. Common modes described are A/C, SIMV, PCV, and PSV. Parameters like tidal volume, respiratory rate, and pressures are adjusted based on patient factors. Monitoring involves vital signs, ventilation assessment, and equipment checks. Extubation criteria focus on spontaneous breathing trials and respiratory parameters
This document discusses Gastroesophageal Reflux Disease (GERD). It defines GERD as a condition that occurs when stomach contents reflux into the esophagus, leading to troublesome symptoms. Common symptoms of GERD include heartburn, indigestion, belching, hiccups, and regurgitation of bitter acid into the mouth. The document then discusses treatments for GERD, including lifestyle modifications, medications like H2 blockers, proton pump inhibitors, and prokinetics, as well as surgical options. It provides details on the mechanisms of different drug classes used to treat GERD and manage its symptoms.
This document provides information on chemotherapeutic drugs and antimicrobial mechanisms of action and resistance. It begins by outlining the learning objectives which are to describe the principles of chemotherapy, mechanisms of antimicrobial drug action and resistance, specific drug classes and their effects. It then discusses the basic principles of chemotherapy and antimicrobials before explaining various mechanisms of antimicrobial action and how selective toxicity is achieved. The document closes by discussing antimicrobial resistance and complications of drug therapy.
This document discusses various diseases of the liver including hepatic failure, cirrhosis, hepatitis, tumors, and inborn errors. It describes the clinical features and morphological alterations that can cause liver failure such as massive hepatic necrosis from viruses, drugs, or chronic liver disease. Cirrhosis is characterized by fibrosis and regeneration of hepatocytes into parenchymal nodules. Portal hypertension is a consequence of cirrhosis and can result in ascites, portosystemic shunts, splenomegaly, and hepatic encephalopathy. Viral hepatitis includes hepatitis A, B, C, D, and E which are transmitted through various routes and can cause acute or chronic disease. Alcoholic liver disease encompasses hepatic ste
This document discusses diarrhea, including its causes, symptoms, diagnosis and treatment. It notes that diarrhea is caused by viruses, bacteria, parasites and other factors. The most common infectious causes in children are rotavirus and Giardia. Diarrhea can lead to dehydration, electrolyte imbalances and other complications if not properly treated. Treatment involves oral rehydration with fluids like ORS, continued feeding and monitoring for dehydration. Preventive measures include breastfeeding, safe water/sanitation, handwashing and vaccination.
This document discusses neonatal jaundice (hyperbilirubinemia) in newborns. It begins by explaining that jaundice is caused by elevated bilirubin levels, which is a normal occurrence in many newborns due to immature liver function and the breakdown of red blood cells. The document then covers the assessment, types (physiological vs pathological), risk factors, causes, investigations and management of neonatal jaundice. Key points include that physiological jaundice is common in the first week of life but requires treatment if bilirubin levels rise too quickly or become too high. Treatment options discussed are phototherapy and exchange transfusion.
Disorder of fluid and electrolytes.pptxMesfinShifara
This document provides guidelines for initial electrolyte management in infants receiving intravenous fluids, with a focus on sodium, potassium, calcium, and disorders related to abnormalities in these electrolytes. It recommends:
- Daily electrolyte measurements for infants receiving only IV fluids, especially very preterm infants under 750g.
- Starting calcium supplementation on the first day for high-risk infants.
- Not adding sodium or potassium to IV fluids for the first few days until levels begin to fall.
- Maintaining sodium at 2-4 mEq/kg/day and potassium at 1-3 mEq/kg/day once supplementation begins.
- Carefully managing abnormalities like hyponatremia, hypernatremia
Congenital pneumonia is a lung infection that is present at birth. It occurs when an infant contracts a pneumonia-causing pathogen while in the mother's womb. Symptoms may include fast breathing, fever, poor feeding, and cough.
Satisfying Spa Massage Experience at Just 99 AED - Malayali Kerala Spa AjmanMalayali Kerala Spa Ajman
Our Spa Massage Center Ajman prioritizes efficiency to ensure a satisfying massage experience for our clients at Malayali Kerala Spa Ajman. We offer a hassle-free appointment system, effective health issue identification, and precise massage techniques.
Our Spa in Ajman stands out for its effectiveness in enhancing wellness. Our therapists focus on treating the root cause of issues, providing tailored treatments for each client. We take pride in offering the most satisfying Pakistani Spa service, adjusting treatment plans based on client feedback.
For the most result-oriented Russian Spa treatment in Ajman, visit our Massage Center. Our Russian therapists are skilled in various techniques to address health concerns. Our body-to-body massage is efficient due to individualized care and high-grade massage oils.
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
The Ultimate Guide in Setting Up Market Research System in Health-TechGokul Rangarajan
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
"Market Research it too text-booky, I am in the market for a decade, I am living research book" this is what the founder I met on the event claimed, few of my colleagues rolled their eyes. Its true that one cannot over look the real life experience, but one cannot out beat structured gold mine of market research.
Many 0 to 1 startup founders often overlook market research, but this critical step can make or break a venture, especially in health tech.
But Why do they skip it?
Limited resources—time, money, and manpower—are common culprits.
"In fact, a survey by CB Insights found that 42% of startups fail due to no market need, which is like building a spaceship to Mars only to realise you forgot the fuel."
Sudharsan Srinivasan
Operational Partner Pitchworks VC Studio
Overconfidence in their product’s success leads founders to assume it will naturally find its market, especially in health tech where patient needs, entire system issues and regulatory requirements are as complex as trying to perform brain surgery with a butter knife. Additionally, the pressure to launch quickly and the belief in their own intuition further contribute to this oversight. Yet, thorough market research in health tech could be the key to transforming a startup's vision into a life-saving reality, instead of a medical mishap waiting to happen.
Example of Market Research working
Innovaccer, founded by Abhinav Shashank in 2014, focuses on improving healthcare delivery through data-driven insights and interoperability solutions. Before launching their platform, Innovaccer conducted extensive market research to understand the challenges faced by healthcare organizations and the potential for innovation in healthcare IT.
Identifying Pain Points: Innovaccer surveyed healthcare providers to understand their difficulties with data integration, care coordination, and patient engagement. They found widespread frustration with siloed systems and inefficient workflows.
Competitive Analysis: Analyzed competitors offering similar solutions in healthcare analytics and interoperability. Identified gaps in comprehensive data aggregation, real-time analytics, and actionable insights.
Regulatory Compliance: Ensured their platform complied with HIPAA and other healthcare data privacy regulations. This compliance was crucial to gaining trust from healthcare providers wary of data security issues.
Customer Validation: Conducted pilot programs with several healthcare organizations to validate the platform's effectiveness in improving care outcomes and operational efficiency. Gathered feedback to refine features and user interface.
About CentiUP - Introduction and Products.pdfCentiUP
A heightened child formula, with the trio of Nano Calcium, HMO, and DHA mixed in the golden ratio, combined with NANO technology to help nourish the body deeply and comprehensively, helps children increase height, boost brain power, and improve the immune system and overall well-being.
Health Tech Market Intelligence Prelim Questions -Gokul Rangarajan
The Ultimate Guide to Setting up Market Research in Health Tech part -1
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
This lays foundation of scoping research project what are the
Before embarking on a research project, especially one aimed at scoping and defining parameters like the one described for health tech IT, several crucial considerations should be addressed. Here’s a comprehensive guide covering key aspects to ensure a well-structured and successful research initiative:
1. Define Research Objectives and Scope
Clear Objectives: Define specific goals such as understanding market needs, identifying new opportunities, assessing risks, or refining pricing strategies.
Scope Definition: Clearly outline the boundaries of the research in terms of geographical focus, target demographics (e.g., age, socio-economic status), and industry sectors (e.g., healthcare IT).
3. Review Existing Literature and Resources
Literature Review: Conduct a thorough review of existing research, market reports, and relevant literature to build foundational knowledge.
Gap Analysis: Identify gaps in existing knowledge or areas where further exploration is needed.
4. Select Research Methodology and Tools
Methodological Approach: Choose appropriate research methods such as surveys, interviews, focus groups, or data analytics.
Tools and Resources: Select tools like Google Forms for surveys, analytics platforms (e.g., SimilarWeb, Statista), and expert consultations.
5. Ethical Considerations and Compliance
Ethical Approval: Ensure compliance with ethical guidelines for research involving human subjects.
Data Privacy: Implement measures to protect participant confidentiality and adhere to data protection regulations (e.g., GDPR, HIPAA).
6. Budget and Resource Allocation
Resource Planning: Allocate resources including time, budget, and personnel required for each phase of the research.
Contingency Planning: Anticipate and plan for unforeseen challenges or adjustments to the research plan.
7. Develop Research Instruments
Survey Design: Create well-structured surveys using tools like Google Forms to gather quantitative data.
Interview and Focus Group Guides: Prepare detailed scripts and discussion points for qualitative data collection.
8. Sampling Strategy
Sampling Design: Define the sampling frame, size, and method (e.g., random sampling, stratified sampling) to ensure representation of target demographics.
Participant Recruitment: Plan recruitment strategies to reach and engage the intended participant groups effectively.
9. Data Collection and Analysis Plan
Data Collection: Implement methods for data gathering, ensuring consistency and validity.
Analysis Techniques: Decide on analytical approaches (e.g., statistical
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVedanta A
Air Ambulance Services In Rewa works in close coordination with ground-based emergency services, including local Emergency Medical Services, fire departments, and law enforcement agencies.
More@: https://tinyurl.com/2shrryhx
More@: https://tinyurl.com/5n8h3wp8
Simple Steps to Make Her Choose You Every DayLucas Smith
Simple Steps to Make Her Choose You Every Day" and unlock the secrets to building a strong, lasting relationship. This comprehensive guide takes you on a journey to self-improvement, enhancing your communication and emotional skills, ensuring that your partner chooses you without hesitation. Forget about complications and start applying easy, straightforward steps that make her see you as the ideal person she can't live without. Gain the key to her heart and enjoy a relationship filled with love and mutual respect. This isn't just a book; it's an investment in your happiness and the happiness of your partner
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...DrDevTaneja1
Digital India will need a big trained army of Health Informatics educated & trained manpower in India.
Presently, generalist IT manpower does most of the work in the healthcare industry in India. Academic Health Informatics education is not readily available at school & health university level or IT education institutions in India.
We look into the evolution of health informatics and its applications in the healthcare industry.
HIMMS TIGER resources are available to assist Health Informatics education.
Indian Health universities, IT Education institutions, and the healthcare industry must proactively collaborate to start health informatics courses on a big scale. An advocacy push from various stakeholders is also needed for this goal.
Health informatics has huge employment potential and provides a big business opportunity for the healthcare industry. A big pool of trained health informatics manpower can lead to product & service innovations on a global scale in India.
Solution manual for managerial accounting 18th edition by ray garrison eric n...rightmanforbloodline
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
2. OBJECTIVES
By the end of this session, you are expected to:
• Define dysmenorrhea
• Differentiate types of dysmenorrhea
• Discuss management of dysmenorrhea
3. Normal menstruation
• Normal menstruation is defined as:
• Frequency – 21 to 40 days.
• Regularity – Variation ≤7 to 9 days b/n the shortest to
longest cycles.
• Duration – ≤8 days.
• Volume –≤80 mL vaginal "blood" loss per cycle.
• The menstrual fluid is normally non-clotting because a
fibrinolysin is released along with the necrotic
endometrial material.
4. Menstrual disorders
1. DYSMENORRHOEA- Painful menstruation.
• It is one of the most common women’s problems.
• Most common in adolescence, usually 4-5yrs of menarche.
• Painful periods become less common as women age.
CAUSE OF DYSMENORRHEA
• Prostaglandins are chemicals that are formed in the lining of the
uterus during menstruation.
• These prostaglandins cause muscle contractions in the Ux, w/c
cause pain & decrease blood flow & oxygen to the Ux.
• Similar to labor pains, cause significant pain & discomfort.
5. TYPES
A. Primary(spasmodic)dysmenorrhea-
• Presence of recurrent, crampy, lower abdominal pain that
occurs during menses in the absence of disease
Due to prostaglandin-induced Uterine contractions and
ischemia.
Begins 6 months - 2 years after menarche.
• MECHANISMS: Excess production of endometrial PGF2 &
E2, but not plasma.
• These compounds can cause dysrhythmia Ux contractions,
hyper-contractility, and increased Ux muscle tone leading to
ischemia.
• They also can account for nausea, vomiting, and diarrhea
6. B. Secondary dysmenorrhea
Menstrual pain due to organic disease.
This is rare before 25 years, worsens with age.
Associated dyspareunia, AUB, infertility.
Involves an underlying physical cause,
– Endometriosis – Uterine fibroids.
– Adenomyosis -- Ovarian cysts
– Pelvic inflammatory disease (PID).
– Use of an intrauterine device (IUD).
6
7. DYSMENORRHEA SYMPTOMS
• The pain of dysmenorrhea is crampy and usually located in
lower abdomen above the pubic bone, back or thighs.
• BEGINS just before or as menstrual bleeding begins, and
gradually diminishes over one to three days.
• Usually occurs intermittently, ranging from mild to disabling.
• Other symptoms that may accompany cramping include
nausea, diarrhea, dizziness, fatigue, headache- cramping
upset stomach & hormonal fluctuation.
8. DIAGNOSIS OF DYSMENORRHEA
• BASED upon a woman's medical history and physical exam.
PHYSICAL EXAMINATION
Complete abdominal and pelvic examination.
During the examination- observe and feel the size and
shape of the Vx, Cx, Ux, and ovaries.
• An internal pelvic examination may not be necessary in
adolescent girls.
Other tests
• In some women, pelvic U/S (vaginally if possible) can be
useful in determining if conditions such as Ux fibroids,
adenomyosis, or endometriosis are present.
9. DYSMENORRHEA TREATMENT
• Number of Treatments are available
NSAIDs
NSAIDs are most effective if started early (for 2-3 days).
NSAIDs; are prostaglandin syntheses inhibitors- often
alleviate the symptoms of primary dysmenorrhea.
– Prescribe ibuprofen 400-600 mg every 4-6hrs or 800 mg
every 8hrs to a max. dose of 2400 mg per day.
10. DYSMENORRHEA TREATMENT……
• Birth control pills - Birth control pills and other forms
of hormonal birth control (one active tablet for 42
consecutive days).
Decrease the uterine contractions and menstrual
bleeding that contribute to pain and cramping.
• Intrauterine device (IUD) - contains the hormone
levonorgestrel (Mirena, Skyla, Liletta) can reduce
dysmenorrhea by as much as 50 percent.
11. Non-pharmacologic Rxs - do not require the use of
medication.
• In some cases, these treatments are not as effective as
medications.
• Heat - Apply heat to the lower abdomen with a heating pad,
hot water bottle speed the relief of pain.
• Exercise and sexual activity- has a number of benefits,
so it is reasonable to try exercising to reduce painful periods.
• Sexual activity may be helpful.
• Anecdotal experience suggests menses-related discomfort is
relieved by orgasm in some women – release of endorphin.
DYSMENORRHEA TREATMENT……
13. OBJECTIVES
By the end of this session, you are expected to:
• Define Amenorrhea
• Differentiate types of Amenorrhea
• Discuss management of Amenorrhea
14. Amenorrhea
14
Events of Puberty
Thelarche (breast development)
Requires estrogen.
Pubarche/adrenarche (pubic hair development)
Requires androgens.
Menarche(the first menses) Requires:
GnRH from the hypothalamus.
FSH and LH from the pituitary.
Estrogen and progesterone from the ovaries.
Normal outflow tract.
15. 1. Primary - absence of menarche by age 15 years or
2. Secondary - absence of menses for more than 3months in
girls/women who previously had regular menstrual cycles or
Six months in girls/women who had irregular menses).
• Missing a single menstrual period may not be important to
assess.
• Absence of menses can be a transient, intermittent, or
permanent condition resulting from dysfunction of
The hypothalamus, pituitary, ovaries, Ux, or Vx.
Definition of Amenorrhea
16. CAUSES
• Primary amenorrhea is usually the result of a genetic or
anatomical abnormality.
However, all causes of secondary amenorrhea can
also be causes for primary amenorrhea.
• Gonadal dysgenesis, including Turner syndrome – 43 %.
• Müllerian agenesis (absence of vagina & uterus) – 15 %.
• Polycystic ovary syndrome (PCOS) – 7 %.
• Transverse vaginal septum – 3 %.
• Weight loss/anorexia nervosa – 2 %.
• Hypopituitarism – 2 %.
17. Possible results of amenorrhea
1. Cannot conceive.
2. Lead to osteoporosis and genital atrophy.
2. Increased endometrial hyperplasia endometrial Ca
from unopposed estrogen secretion.
Without 2o sexual chxs may give rise to major social and
psychosexual problems.
Classification of The Main of amenorrhea
• Hypothalamic amenorrhea.
• Pituitary amenorrhea.
• Ovarian amenorrhea.
• Uterine amenorrhea.
17
18. 1-Hypothalamic amenorrhea
Low energy availability (from decreased caloric
intake, excessive energy expenditure, or both) and
Stress are common causes of hypo gonadotropic hypo-
gonadism in women.
Etiology
– Psychological stress, Anorexia nervosa, weight loss,
Increased exercise levels.
– Kallmann syndrome-congenital absence of GnRH.
– Drug-induced amenorrhea: anti-psychotics, reserpine,
Contraceptive, Space-occupying lesion of CNS.
18
19. Weight-related amenorrhoea: Anorexia Nervosa
• Anorexia nervosa is an eating d/r that makes
people want to weigh less than is healthy.
• A body mass index (BMI) <17 kg/m²
menstrual irregularity and amenorrhea.
• Hypothalamic suppression.
• Low estradiol risk of osteoporosis
• Low energy availability can suppress the
hypothalamic-pituitary-ovarian (HPO) axis,
diverting energy away from reproductive
processes to more vital systems 19
20. Exercise-associated amenorrhea
• Common in women who participate in sports.
• Strenuous exercise that is not matched by energy intake
increases the likelihood of menstrual dysfunction.
• Eating disorders have a higher prevalence in female
athletes than non-athletes.
20
21. Stress
• Stressors activate the hypothalamic-pituitary-adrenal (HPA)
axis,
with increased secretion of hypothalamic corticotropin-
releasing hormone (CRH), corticotropin (ACTH), and
adrenal cortisol secretion.
• CRH inhibits GnRH pulse frequency, and cortisol suppresses
reproductive function at the hypothalamic, pituitary, and
uterine levels.
• Extreme physical, nutritional, and/or emotional stress
negatively affect reproduction throughout the HPO axis.
22. Contraception related amenorrhea
• Depo
– 80 % of women will have amenorrhea after 1 year of use.
– It is reversible (estrogen deficiency).
• A minority of women taking the POP may have reversible long
term amenorrhea due to complete suppression of ovulation
22
23. 2-pituitary amenorrhea
23
Etiology
• Pituitary inability to secrete gonadotropins.
• Pituitary necrosis following massive obstetric hemorrhage is
most common cause in women.
• Diagnosis : History and E2,FSH,LH
Treatment :
Replacement of deficient hormones.
25. 4- Uterine
Etiology
• Uterine amenorrhea
– Absence of uterus
– Utero-vaginal agenesis-15% of primary amenorrhea
– Asherman syndrome
• Anatomic abnormalities of the reproductive tract
– Imperforate hymen.
Diagnosis of amenorrhea
• History
• Physical examination
– PE begins with vital signs, including height and wt
– Laboratory evaluation: hormonal profile. 25
26. Evaluation of Primary Amenorrhea
– Physical exam to determine presence of uterus.
– FSH
– Karyotype
• Is there normal development of secondary sexual
characteristics? NO
Think hypogonadism or hypogonadotropism
• Is there normal development of secondary sexual
characteristics?YES
Think: Pregnancy, Mullerian anomaly, Androgen insensitivity
26
27. Evaluation of Secondary Amenorrhea
History
– Nutrition/exercise habits, weight change
– Sexual / contraceptive practice
– History of uterine/cervical surgery
• Physical exam
– Height/weight
– Hirsutism
– Galactorrhea
– Estrogen status of tissues
• Laboratory
– hCG PRL & TSH progesterone challenge FSH if
high karyotype 27
28. Management of Primary Amenorrhea
• Treatment of primary amenorrhea is directed at correcting
the underlying pathology (if possible)
• Helping the woman to achieve fertility, and
• Prevention of complications of the disease process (e.g.
estrogen replacement to prevent osteoporosis).
• Psychological counseling is particularly important in patients
with absent müllerian structures and/or a Y chromosome.
• Surgery may be required in patients with either congenital
anatomic lesions or Y chromosome material.
28
29. Management of Primary ....
• In with hypoestrogenism, hormone replacement is important
to prevent bone loss and potential excess risk of premature
coronary heart disease.
• Functional hypothalamic amenorrhea can usually be
reversed by
weight gain, reduction in the intensity of
exercise, and/or resolution of illness or emotional stress.
• For women who want to continue to exercise or are unable
to improve their nutritional health,
estrogen-progestin replacement therapy to those not
seeking fertility to improve bone mineral density
29
30. Management of Secondary Amenorrhea
The overall goals of management in women with secondary
amenorrhea include:
• Correcting the underlying pathology, if possible
• Helping the woman to achieve fertility, if desired
• Preventing complications of the disease process (eg,
estrogen replacement to prevent osteoporosis)
30
Prostaglandins are released during menstruation, due to the destruction of the endometrial cells, and the resultant release of their contents. Release of prostaglandins and other inflammatory mediators in the uterus cause the uterus to contract. These substances are thought to be a major factor in primary dysmenorrhea.
Nausea during your period can also be caused by a mild fluctuation of sex hormones, which prompts the stomach to overproduce gastric juices containing hydrochloric acid. This can cause mild heartburn or, in extreme cases, vomiting.
Secondary dysmenorrhea is more common among women in the 4th & 5th decades of life, but occasionally occurs in adolescents.
Do you get nauseated before or during period?
The cramping that usually accompanies the menstrual period is the primary cause of this upset stomach and it can occur before, during or after a woman's period. However, this nausea could also be caused by excess stomach acid that comes from the changes and imbalance in hormones during the menstrual cycle
Anecdotal experience - of an account) not necessarily true or reliable, because based on personal accounts rather than facts or research:"while there was much anecdotal evidence there was little hard fact"
Turner syndrome is an important cause of short stature in girls and primary amenorrhea in adolescents and young women and is caused by loss of part or all of an X chromosome. (45,X/46,XX)
What is anorexia nervosa? — Anorexia nervosa is an eating disorder that makes people want to weigh less than is healthy.
What are the symptoms of anorexia nervosa? — People with anorexia nervosa:
●Weigh much less than they should for their age and height – To lose weight, people eat too little, exercise too much, or do other things, such as make themselves vomit.
●Are very worried about gaining weight – To avoid gaining weight, they will not eat, even when they are hungry.
●See their body and shape in an abnormal way – For example, they:
•Think they are fat, even when they are underweight
•Don't understand that their low body weight can cause serious medical problems
•Feel good about themselves when they lose weight and bad when they gain weight
It is also common for people with anorexia nervosa to:
●Spend a lot of time thinking about food, meals, and calories
●Create rules around food and eating
●Skip meals and avoid eating in public